Sit Acquires Potasion From Sanofi
SIT Group is pleased to announce the acquisition of established product SULMETIN from Sanofi, as a result of the agreement signed on November 8, 2022.
This additional acquisition in Spain market increases DESMA Spain’s footprint and business.